Evolution of COVID-19 case curve in cities belonging the northwest macro-region of the Paraná State, Brazil
DOI:
https://doi.org/10.33448/rsd-v9i12.10978Keywords:
Notifica COVID-19 program; Coronavirus; SARS-CoV-2; Sentinel program.Abstract
Objective: this study consisted of a survey of the number of cases/deaths from the coronavirus COVID-19 in the northwest macro-region of the state of Paraná, Brazil. Methodology: the data were obtained from Epidemiological Bulletins provided by the Health Department of the State of Paraná, from Notifica Coronavirus Program (COVID-19) in the period from March to September 2020. Information used from the regional health center of the northwest macro-region, which correspond to the 11th Campo Mourão Regional Health Center, 12th Umuarama Regional Health Center, 13th Cianorte Regional Health Center, 14th Paranavaí Regional Health Center and 15th Maringá Regional Health Center. Results: it was found that there was a linear increase in the reported cases of COVID-19 in the period evaluated in the five cities in the state of Paraná , with 177,007 people infected and 4,441 deaths throughout the state. The city with the highest number of cases/death was Maringá (13,256 cases and 225 deaths), and conversely Paranavaí (1668 cases and 41 deaths) had the lowest number of cases/deaths. There was a significant increase in the number of cases as of june/2020, justified by the mass testing of the population that started on May 29th, 2020, and by the beginning of the winter season in the southern region of Brazil, which causes every year high incidences of lung diseases. Conclusion: to date there is no effective treatment available, with a prognosis that until December/2020 there will be a vaccine to immunize the entire population.
References
Alonso, W. J., Schuck-Paim, C., Freitas, A. R. R., Kupek, E., Wuerzius, C. R., Negro-Calduch, E., Fernandes, R. M., Cristo, E. B., Veiga, A. B. G., Giglio, R., Abraão, M. S., Pinheiro, S. F. (2020). Covid-19 em contexto: comparação com a mortalidade mensal por causas respiratórias nos estados brasileiros. InterAmerican Journal of Medicine and Health, 3, 1-21. doi: 10.31005/iajmh.v3i0.93.
Amorim, V. C., Monteiro, T. M., Almeida, J. A. T., Vanderlon, Y., & Abdala, M. (2020). Promoção de isolamento social na pandemia de covid-19: considerações da análise comportamental da cultura. Rev. Bras. Anal, 16, 1. doi: 10.18542/rebac.v16i1.8886.
Bentes, R. N. (2020). A covid-19 no Brasil e as atribuições dos agentes comunitários de saúde: desafios e problemáticas enfrentados no cenário nacional de pandemia. Hygeia-Revista Brasileira de Geografia Médica e da Saúde, 175-182. doi: 10.14393/Hygeia0054404.
Brasil (2020a, abril 06). Diretrizes para Diagnóstico e Tratamento da Covid-19. (2020a) Secretaria de Ciência, Tecnologia, Inovação e Insumos Estratégicos em Saúde - SCTIE. Recuperado de: https://sbim.org.br/images/files/notas-tecnicas/ddt-covid-19-200407.pdf.
Brasil (2020b, junho 25). Ministério da Saúde. Saúde passa a testar casos leves de Covid-19. Recuperado de: <https://www.gov.br/saude/pt-br/assuntos/noticias/saude-passa-a-testar-100-dos-casos-leves-de-covid-19> .
Brasil (2020c, setembro 30). Secretaria de Vigilância em Saúde. Doença pelo Coronavírus COVID-19. Boletim Epidemiológico Especial. Semana Epidemiológica 39 (20 a 26/09/2020). Recuperado de: (https://antigo.saude.gov.br/images/pdf/2020/October/01/Boletim-epidemiologico-COVID-33-final.pdf).
Brasil (2015). Vigilância Sentinela de Síndrome Gripal (Sg) no Brasil. Coordenação Geral de Doenças Transmissíveis (CGDT). Secretaria de Vigilância em Saúde (SVS). (2015). Recuperado de: (https://www.saude.pr.gov.br/sites/default/arquivos_restritos/files/documento/2020-04/vigilancia_sentinela_de_sg_no_brasil_final.pdf).
Cascella, M., Rajnik, M., Cuomo, A., Dulebohn, S. C., & Di Napoli, R. (2020). Features, evaluation and treatment coronavirus (COVID-19). In Statpearls [internet]. StatPearls Publishing. Recuperado de: https://www.ncbi.nlm.nih.gov/books/NBK554776/.
Carvalho, W., & Teixeira, L. A. (2020). As máscaras faciais podem proteger contra a COVID-19?. InterAmerican Journal of Medicine and Health, 3. doi: 10.31005/iajmh.v3i0.132
Croda, J. H. R., & Garcia, L. P. (2020). Resposta imediata da Vigilância em Saúde à epidemia da COVID-19. doi: 10.5123/S1679-49742020000100021
Guimarães, R. (2020). Anti-Covid vaccines: a look from the Collective Health. Ciencia & saude coletiva, 25, 3579-3585. doi: 10.1590/1413-81232020259.24542020
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., Cheng, Z., Yu, T., Xia, J., Wei, Y., Wu, W., Xie, X., Yin, W., Li, H., Liu, M., Xiao, Y., Gao, H., Guo, L., Xie, J., Wang, G., Jiang, R., Gao, Z., Jin, Q., Wang, J., & Cao, B. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet, 395(10223), 497-506. doi: 10.1016/S0140-6736(20)30183-5.
IBGE. Instituto Brasileiro de Geografia e Estatística População estimada estado de Maringá [Internet]. (2020, julho 1). Recuperado de: https://www.ibge.gov.br/cidades-e-estados/pr/maringa.html.
IN LOCO- Mapa brasileiro da COVID-19 - Índice de isolamento social (Internet). (2020, outubro, 8). Recuperado de: https://mapabrasileirodacovid.inloco.com.br/pt/).
Khalifa, I., Zhu, W., Nafie, M. S., Dutta, K., & Li, C. (2020). Anti-COVID-19 Effects of Ten Structurally Different Hydrolysable Tannins through Binding with the Catalytic-Closed Sites of COVID-19 Main Protease: An In-Silico Approach. Recuperado de: https://www.researchgate.net/profile/Ibrahim_Khalifa7/publication/339999895_Anti-COVID-19_effects_of_ten_structurally_different_hydrolysable_tannins_through_binding_1_with_the_catalytic-closed_sites_of_COVID-19_main_protease_An_in-silico_approach_2/links/5e71f903a6fdcc37caf3545f/Anti-COVID-19-effects-of-ten-structurally-different-hydrolysable-tannins-through-binding-1-with-the-catalytic-closed-sites-of-COVID-19-main-protease-An-in-silico-approach-2.pdf.
Lana, R. M., Coelho, F. C., Gomes, M. F. D. C., Cruz, O. G., Bastos, L. S., Villela, D. A. M., & Codeço, C. T. (2020). Emergência do novo coronavírus (SARS-CoV-2) e o papel de uma vigilância nacional em saúde oportuna e efetiva. Cadernos de Saúde Pública, 36, e00019620. doi: 10.1590/0102-311X00019620 .
Lurie, N., Saville, M., Hatchett, R., & Halton, J. (2020). Developing Covid-19 Vaccines at Pandemic Speed. New England Journal of Medicine, 382(21), 1969-1973. doi: 10.1056/NEJMp2005630.
Mccreary, E. K., & Pogue, J. M. (2020). Coronavirus Disease 2019 Treatment: A Review of Early and Emerging Options. Open Forum Infectious Diseases, 7(4). doi: 10.1093/ofid/ofaa105.
Pereira, A. S., Shitsuka, D. M., Parreira, F. B. & Shitsuka, R. (2018, dezembro 14). Metodologia da pesquisa científica [recurso eletrônico [eBook]. Santa Maria. Ed. UAB / NTE / UFSM. Recuperado de:https://repositorio.ufsm.br/bitstream/handle/1/15824/Lic_Computacao_MetodologiaPesquisa-Cientifica.pdf?sequence=1.
Ren, L. L., Wang, Y. M., Wu, Z. Q., Xiang, Z. C., Guo, L., Xu, T., Jiang, Y. Z., Xiong, Y., Li, Y. J., Li, X. W., Li, H., Fan, G. H., Gu, X. Y., Xiao, Y., Gao, H., Xu, J. Y., Yang, F., Wang, X. M., Wu, C., Chen, L., Liu, Y. W., Liu, B., Yang, J., Wang, X. R., Dong, J., Li, L., Huang, C. L., Zhao, J. P., Hu, Y., Cheng, Z. S., Liu, L. L., Qian, Z. H., Qin, C., Jin, Q., Cao, B., & Rothan, H. A. & Byrareddy S. N. (2020). Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study. Chinese medical journal. doi: 10.1097/CM9.0000000000000722.
Sousa, H. M. de, Torres, N. M. F., Moura, M. C. L. de., Silva, R. P. da., Araújo, V. L. L., & Sousa, R. A. de. (2020). Comparison of data on deaths by Covid-19 between three sources of information, Maranhão. Res., Soc. Dev, 9(9), e94996894. doi: 10.33448/rsd-v9i9.6894.
Souto, X. M. (2020). COVID-19: general aspects and global implications. RECITAL, 2(1), 2674-9270. doi: 10.46636/recital.v2i1.90.
Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., Zhao, Y., Li, Y., Wang, X., Peng, Z. (2020a). Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China. Jama, 323(11), 1061. doi: 10.1001/jama.2020.1585.
Wang, W., Tang, J., & Wei, F. (2020b). Updated understanding of the outbreak of 2019 novel coronavirus (2019‐nCoV) in Wuhan, China. Journal of Medical Virology, 92(4), 441-447. doi: 10.1002/jmv.25689.
Wang, J. W. (2020). Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study. Chin Med J (Engl)., 133(9), 1015-1024. doi: 10.1097/CM9.0000000000000722.
Wong, C. H., Siah, K. W., & Lo, A. (2019). Estimation of clinical trial success rates and related parameters. Rev Biostatistics, 20(2), 273-286. doi: 10.1093/biostatistics/kxx069.
World Health Organization (2020, outubro 4). WHO Coronavirus Disease (COVID-19) Dashboard. Recuperado de: https://covid19.who.int/.
Zhi, Z. L. X. B. X. Z. (2020). The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19). China CDC Weekly. 113-122. doi: 10.3760/cma.j.issn.0254-6450.2020.02.003.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 Marcos Rodrigo da Silva; Gabriella Santana de Oliveira; Juliana Aparecida Mendonça; Marcella Ribeiro da Costa; Marisangela Isabel Wietzikoski Halabura; Wanessa de Campos Bortolucci; Nelson Barros Colauto; Giani Andrea Linde; Carla Maria Mariano Fernandez; Maria Graciela Iecher Faria; Juliana Silveira do Valle; Zilda Cristiani Gazim
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
